Leading the Institute of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-University in Aachen

Since 2008 Professor Dr. Fabian Kiessling is leading the Institute of Experimental Molecular Imaging at the Helmholtz Institute for Biomedical Engineering at the RWTH-University in Aachen. Aim of his research is the development of novel diagnostic, theranostic and therapeutic probes as well of advanced imaging technologies and image analysis tools. In this context, a main focus of his research is the investigation and diagnostic assessment of vascular and microenvironmental tissue properties and the exploration of its impact on disease progression and therapy response.

Fabian Kiessling studied Medicine and did his thesis at the University in Heidelberg. Until the end of 2002, he worked as resident in the Department of Radiology at the German Cancer Research Center (DKFZ) in Heidelberg. In 2003 he changed to the Department of Medical Physics in Radiology of the DKFZ as leader of the Molecular Imaging group. In parallel, he did his clinical training at different Departments of the University of Heidelberg and received the board certification as Radiologist in 2007. Fabian Kiessling did his habilitation in experimental radiology in 2006. In 2008 he founded the invivoContrast GmbH together with Matthias Braeutigam.

Fabian Kiessling is author of more than 400 scientific publications and book chapters, edited four books and received many research awards, among those the „Emil Salzer Price for Cancer Research” and the “Richtzenhain Price”. Furthermore, he was awarded as Fellow of the World Molecular Imaging Society in 2019 and in 2019 and 2020 identified as “Highly Cited Researcher” by Clarivate Analytics (Web of Science).

He is founding member of the European Society for Functional and Molecular Imaging in Radiology (ESMOFIR), served as treasurer and secretary of the European Society for Molecular Imaging (ESMI), is founding member of the ESMI working group “Image Guided Therapy and Drug Delivery (IGTDD)“, and was chairman of the “Molecular Imaging” subcommittee of the European Society for Radiology (ESR). In addition, he is member of the Board of Trusties of the World Molecular Imaging Society and was program chair of the World Molecular Imaging Conference (WMIS) in New York in 2016.